Dr. Natalia Vallianou | Healthcare Data Analysis | Best Researcher Award

Dr. Natalia Vallianou at Evangelismos General Hospital, Greece

👨‍🎓 Profiles

đź“š Early Academic Pursuits

Dr. Natalia Vallianou began her academic journey at the University of Thessaly, where she earned her degree in Medicine with honors from 1991 to 1997. During her medical training, she built a strong foundation in various medical disciplines, which prepared her for her specialization in infectious diseases. Following graduation, she pursued a Master of Science (MSc) in Infectious Diseases at the University of Athens from 1998 to 2000, gaining critical knowledge essential for her future endeavors. Dr. Vallianou completed her residency in Internal Medicine between 1999 and 2004, honing her clinical skills before earning her PhD with research focused on antibiotic resistance in Staphylococci.

🏥 Professional Endeavors

Currently, Dr. Vallianou serves as the Director of the First Department of Internal Medicine at Sismanogleio General Hospital in Athens, a role she has held since January 2024. Previously, she worked as a Consultant in Internal Medicine at Evangelismos General Hospital from July 2009 to January 2024, where she influenced patient care and clinical training. Her earlier experience at Polikliniki General Hospital further solidified her expertise. Additionally, her work at the Laboratory of Infectious Diseases involved critical research and patient care, allowing her to merge clinical practice with scientific inquiry.

🔬 Contributions and Research Focus

Dr. Vallianou’s research primarily focuses on infectious diseases, antimicrobial resistance, and clinical microbiology. She has authored an impressive 155 publications in international scientific journals, with 124 indexed in PubMed. Her research has appeared in high-impact journals such as Seminars in Cancer Biology and Clinical Microbiology and Infection. Dr. Vallianou has presented at 151 international and Hellenic congresses and serves as a reviewer for prestigious medical journals, reflecting her significant contributions to the field.

🏆 Accolades and Recognition

Throughout her career, Dr. Vallianou has received various accolades for her contributions to medicine and research. Her publications in high-impact journals and active participation in international congresses have established her as a leading voice in infectious diseases. Recognized for her mentorship, she has influenced many medical students and residents, and her proficiency in English and French has enabled her to collaborate globally.

🌍 Impact and Influence

Dr. Vallianou’s impact goes beyond her clinical and research achievements. As a leader in her field, she has influenced practices among healthcare professionals and inspired new generations to prioritize research and evidence-based medicine. Her focus on antimicrobial resistance is particularly relevant, as she contributes to strategies aimed at combating this pressing public health challenge.

đź”® Legacy and Future Contributions

As Dr. Vallianou continues her career, her legacy will be marked by her dedication to improving patient outcomes and advancing the field of infectious diseases. She aims to explore innovative approaches to treatment and prevention of antimicrobial resistance, fostering collaboration between clinicians and researchers to enhance infectious disease management. Her influence will undoubtedly continue to shape the medical landscape for years to come.

📖  Top Noted Publications
Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research
    • Authors: Katia Mangano, Aristidis Diamantopoulos, Natalia G. Vallianou, Theodora Stratigou, Fotis Panagopoulos, Dimitris Kounatidis, Maria Dalamaga, Paolo Fagone, Ferdinando Nicoletti
    • Journal: Metabolism Open
    • Year: 2024
The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: A retrospective study
    • Authors: Efstratios Kardalas, Aggeliki Paikopoulou, Dimitra A. Vassiliadi, Dimitris Kounatidis, Natalia G. Vallianou, Christine Vourlakou, Irene Karampela, Maria Dalamaga, Marinella Tzanela, Theodora Stratigou
    • Journal: Metabolism Open
    • Year: 2024
Kinetics of the Lactate to Albumin Ratio in New Onset Sepsis: Prognostic Implications
    • Authors: Irene Karampela, Dimitris Kounatidis, Natalia G. Vallianou, Fotis Panagopoulos, Dimitrios Tsilingiris, Maria Dalamaga
    • Journal: Diagnostics
    • Year: 2024
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
    • Authors: Dimitris Kounatidis, Nikolaos Tentolouris, Natalia G. Vallianou, Iordanis Mourouzis, Irene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha et al.
    • Journal: Metabolites
    • Year: 2024
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
    • Authors: Natalia Vallianou, Dimitris Kounatidis, Sotiria Psallida, Nikolaos Vythoulkas-Biotis, Andreas Adamou, Tatiana Zachariadou, Sofia Kargioti, Irene Karampela, Maria Dalamaga
    • Journal: Metabolites
    • Year: 2024
Natalia Vallianou | Healthcare Data Analysis | Best Researcher Award

You May Also Like